openPR Logo
Press release

Drug Screening Market Size, Insights, Regional Analysis and Global Outlook 2024-2032 Quest Diagnostics, Abbott Laboratories, Thermo Fisher Scientific

05-16-2024 12:14 PM CET | Health & Medicine

Press release from: Market Digits

Drug Screening Market

Drug Screening Market

The Drug Screening Market is Valued USD 6.6 billion in 2024 and projected to reach USD 27.1 billion by 2032, growing at a CAGR of 16.30% During the Forecast period of 2024-2032. It further allows the industry leaders to penetrate deep into the marketing evaluation with the highest profitability. The research examines parent market trends, macroeconomic data, and controlling factors in depth, as well as Drug Screening market attractiveness by segment. The qualitative influence of key market factors on market segments and regions is also mapped out in the study. This report is a detailed and comprehensive analysis for global Drug Screening market. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets.

Get a Sample PDF of the Report @ https://www.marketdigits.com/request/sample/83?utm_source=PR_MD

The new study offers a brief evaluation of the Drug Screening market statistics, which are subdivided into the regions, countries as well as subregions. This report is helpful to remark the possible estimations and projection regarding the growth strategies of the global Drug Screening market. It also summarizes possible profit opportunities, sales/demand, production as well as consumption analysis, in involvement to Drug Screening industry share in each nation and sub-region. The geographical segment of the Drug Screening market report illustrates the industry share as well as growth rates of each region during the estimated period from 2024 to 2032.

The Drug Screening market report is determined from perspective of upcoming development based on the condition of the existing industry perspective. Several data researchers, and analysts have analyzed crucial products as well as participant data analysis according to major statistic and the elaboration of the segmented geographical regions, end-use industries and application-driven aspects. The whole research report on the Drug Screening market concentrated on the valuable data and various other factors. Additionally, the report delivers a comprehensive overview, pie charts, tables, diagrams, and tables to assist the growth of the Drug Screening market.

Profitable players of the Drug Screening market are: LabCorp (Laboratory Corporation of America Holdings), Quest Diagnostics, Abbott Laboratories, Thermo Fisher Scientific, Inc., Alfa Scientific Designs, Inc., OraSure Technologies, Inc., Siemens Healthcare GmbH, F. Hoffmann-La Roche Ltd, Shimadzu Corporation, LifeLoc Technologies, Drägerwerk AG & Co. KGaA, Premier Biotech, Inc., Quidel Corporation, Bio-Rad Laboratories, Inc., Agilent Technologies, Inc., and Others.

Major Classifications are as follows:

By Product
Drug Screening Product
Analytical Instruments
Breathanalyzers
Fuel Cell Breathalyzer
Semiconductor Breathalyzer
Others

Immunoassay Analyzer
Chromatography Instruments
Rapid Testing Devices
Urine Testing Devices
Drug Testing Cups
Dip Cards
Drug Testing Cassetts
Oral Fluid Testing Devices

Consumables
Assay Kits
Sample Collection Devices
Calibrators & Controls
Others
Drug Screening Service

By Sample Type
Urine samples
Breath Samples
Oral Fluid Samples
Hair Samples
Others

By End-user
Drug testing laboratories
Drug treatment centers
Pain management centers
Hospitals
Others

To establish the important thing traits, Ask Our Experts @ https://www.marketdigits.com/request/enquiry-before-buying/83?utm_source=PR_MD

Essential regions of the Drug Screening market are:

• Drug Screening North America Market includes (Canada, Mexico, USA)
• Drug Screening Europe Market includes (Germany, France, Great Britain, Italy, Spain, Russia)
• Drug Screening Asia-Pacific Market includes (China, Japan, India, South Korea, Australia)
• Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa)
• Drug Screening South America Market includes (Brazil, Argentina)

Drug Screening Industry News:

In April 2022, Saladax Biomedical, Inc acquired a patent portfolio for antipsychotic drug testing from Janssen Pharmaceutica NV. This intellectual property (IP) portfolio includes 17 patent families. This strategy placed the company in a premier position in the antipsychotic drug testing field.

In April 2019, Thermo Fisher Scientific launched Thermo Scientific CEDIA Mitragynine (Kratom) Assay, its newest drugs of abuse test. The CEDIA Mitragynine (Kratom) assay can be run on commonly used clinical chemistry analyzers, allowing a broad spectrum of laboratorians to test for the presence of Kratom. This helped the company to widen its product portfolio.

What's more, it likewise covers the request and give of the promoting research concentrate in the assessed figure time frame. Explained investigation of the market players with their profile, deals examination and serious scene is given in the report. Besides, organization, joint effort and consolidations in the business are referenced for the accommodation of the investigation of the global Drug Screening industry.

Get Complete Report Drug Screening market 2024 for Better Understanding @ https://www.marketdigits.com/drug-screening-market?utm_source=PR_MD

Pivotal questions answered in the global Drug Screening market report:

• What are the major value propositions of the Drug Screening market?
• What are the new strategical frameworks that are mobilized among players to accomplish resilience in the wake of the COVID-19 pandemic?
• What technologies are expected to adopt the new regulations in Drug Screening report?
• What are the key collaborations generated by the vendors to consolidate their position in the Drug Screening market?
• What are the vital offerings new entrants concentrate on to implement unique positioning strategies?
• What are the futuristic prospects of the Drug Screening market across the globe?

Contact Us:

1248 CarMia Way Richmond,
VA 23235, United States.
Phone: +1 510-730-3200
Email: sales@marketdigits.com
Website: https://www.marketdigits.com

About MarketDigits:

MarketDigits is one of the leading business research and consulting companies that helps clients to tap new and emerging opportunities and revenue areas, thereby assisting them in operational and strategic decision-making. We at MarketDigits believe that a market is a small place and an interface between the supplier and the consumer, thus our focus remains mainly on business research that includes the entire value chain and not only the markets.

We offer services that are most relevant and beneficial to the users, which help businesses to sustain themselves in this competitive market. Our detailed and in-depth analysis of the markets catering to strategic, tactical, and operational data analysis & reporting needs of various industries utilize advanced technology so that our clients get better insights into the markets and identify lucrative opportunities and areas of incremental revenues.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Drug Screening Market Size, Insights, Regional Analysis and Global Outlook 2024-2032 Quest Diagnostics, Abbott Laboratories, Thermo Fisher Scientific here

News-ID: 3498362 • Views:

More Releases from Market Digits

Human Microbiome Market is forecasted to reach USD 2,555 Million by 2030, demonstrating a robust CAGR of 35.8 Percentage | (Viome Life Sciences, Inc., BIOHM Health, DayTwo) - published by MarketDigits
Human Microbiome Market is forecasted to reach USD 2,555 Million by 2030, demons …
Human Microbiome Market Scope: Market size value in 2023 - USD 300 Million Market size value in 2030 - USD 2,555 Million CAGR (2023-2030) - 35.8% Forecast Period - 2023-2030 Segments Covered - Product, Type, Disease, Application and Region. Geographies Covered - North America, Europe, Asia Pacific, and Row Sample of Companies Covered - Atlas Biomed, Bione Ventures Private Limited, Luxia Scientific, Metabiomics, Sun Genomics, Seed Health, Gnubiotics Sciences. Download Sample Pages-https://www.marketdigits.com/request/sample/3619 Browse in-depth TOC on
Human Microbiome Market is forecasted to reach USD 2,555 Million by 2030, demonstrating a robust CAGR of 35.8 Percentage | (Viome Life Sciences, Inc., BIOHM Health, DayTwo) - published by MarketDigits
Human Microbiome Market is forecasted to reach USD 2,555 Million by 2030, demons …
Human Microbiome Market Scope: Market size value in 2023 - USD 300 Million Market size value in 2030 - USD 2,555 Million CAGR (2023-2030) - 35.8% Forecast Period - 2023-2030 Segments Covered - Product, Type, Disease, Application and Region. Geographies Covered - North America, Europe, Asia Pacific, and Row Sample of Companies Covered - Atlas Biomed, Bione Ventures Private Limited, Luxia Scientific, Metabiomics, Sun Genomics, Seed Health, Gnubiotics Sciences. Download Sample Pages-https://www.marketdigits.com/request/sample/3619 Browse in-depth TOC on
Healthcare Cyber Security Market Set to Surpass USD 53.23 Billion by 2030 - published by MarketDigits
Healthcare Cyber Security Market Set to Surpass USD 53.23 Billion by 2030 - publ …
Healthcare Cyber Security Market Scope: Market size value in 2023 - USD 17.27 Billion Market size value in 2030 - USD 53.23 Billion CAGR (2023-2030) - 17.45 % Forecast Period - 2023-2030 Segments Covered - Type of Solution, Type of Threat, End-Use, Type of Security and Region Geographies Covered - North America, Europe, Asia Pacific, and Row Sample of Companies Covered - Cisco, IBM, FireEye, Symantec, Trend Micro, MacAfee, Intel, Kaspersky, Lockheed Martin. Download Sample
Grid Scale Battery Market Size:CAGR of 4.4% during the forecast period Forecast period 2023-2030 | ABB, BYD Co Ltd, S&C Electric Co, Tesla Inc, Toshiba Corporation - published by MarketDigits
Grid Scale Battery Market Size:CAGR of 4.4% during the forecast period Forecast …
Grid Scale Battery Market Scope: Market size value in 2023 - USD 5397 Billion Market size value in 2030 - USD 1,268.5 Billion CAGR (2023-2030) - 12.40% Forecast Period - 2023-2030 Segments Covered - Battery Type, Deployment, Integration, Application, End-use Industry and Region. Geographies Covered - North America, Europe, Asia Pacific, and Row Sample of Companies Covered - ABB, BYD Co Ltd, Limited, Fluence Corporation Ltd, NGK Insulators Ltd, Panasonic Corporation, S&C Electric Co. Download Sample Pages-https://www.marketdigits.com/request/sample/3645 Browse in-depth

All 5 Releases


More Releases for Drug

Injectable Drug Delivery Market Injectable Drug Delivery Market
Leading market research firm SkyQuest Technology Group recently released a study titled ' Injectable Drug Delivery Market Global Size, Share, Growth, Industry Trends, Opportunity and Forecast 2024-2031,' This study Injectable Drug Delivery report offers a thorough analysis of the market, as well as competitor and geographical analysis and a focus on the most recent technological developments. The research study on the Injectable Drug Delivery Market extensively demonstrates existing and upcoming
Global Advanced Drug Delivery Systems Market Size - By Product Type(Oral Drug De …
Market Overview and Report Coverage Advanced Drug Delivery Systems (ADDS) refer to innovative technologies designed to improve the administration and efficacy of therapeutics, enhancing the way medications are delivered to targeted areas within the body. These systems aim to optimize treatment outcomes by increasing the bioavailability, reducing side effects, and facilitating controlled drug release. Employing methods such as nanoparticles, liposomes, and implantable pumps, ADDS are revolutionizing personalized medicine and expanding therapeutic
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Pric …
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Price, and Clinical Trials Outlook 2029 Report Highlights: * Global Antibody Drug Conjugates Market Opportunity: > 40 Billion By 2029 * Global and Regional Antibody Drug Conjugate Market Insight * Approved Drugs Sales Insight Global and Regional, Yearly and Quarterly, 2019 -2023 * Approved Antibody Drug Conjugates - Availability, Dosage and Price Insight * Insight On Antibody Drug Conjugates In Clinical Trials: > 550
Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions. Alcohol abuse and drug
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.  Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Introduction to Hepatitis Disease 1.1 Prologue 1.1.1 History of Hepatitis 1.1.2 Causes of Hepatitis Disease 1.2 Types of Viruses which are Responsible for Hepatitis Disease 2. Global Prevalence of Hepatitis Infection 3. Available Drug Classes for Hepatitis Disease Treatment 3.1 Interferon Alfa Therapy 3.2 Protease Inhibitors Therapy 3.3 Polymerase